The Exposome and Cardiovascular Health
Canadian Journal of Cardiology · 2023-09 · 39 (9) · 1191-1203
DOI: 10.1016/j.cjca.2023.05.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Cardiology, 2023-09. Verfasst von Issam Motairek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Clevel…. Hauptthemen laut MEDLINE: Cardiovascular Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, NIH, National Institute on Minority Health and Health Disparities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Electronic address: sadeer.al-kindi@uhhospitals.org.
Förderung
- NIMHD NIH HHS
- NIH
- National Institute on Minority Health and Health Disparities
Zitieren
APA
Motairek, I., Makhlouf, M. H. E., Rajagopalan, S., & Al-Kindi, S. (2023). The Exposome and Cardiovascular Health. Canadian Journal of Cardiology, 39(9), 1191-1203. https://doi.org/10.1016/j.cjca.2023.05.020
Vancouver
Motairek I, Makhlouf MHE, Rajagopalan S, Al-Kindi S. The Exposome and Cardiovascular Health. Canadian Journal of Cardiology. 2023;39(9):1191-1203. doi:10.1016/j.cjca.2023.05.020
BibTeX
@article{Motairek2023,
author = {Motairek, Issam and Makhlouf, Mohamed H E and Rajagopalan, Sanjay and Al-Kindi, Sadeer},
title = {The Exposome and Cardiovascular Health},
journal = {Canadian Journal of Cardiology},
year = {2023},
volume = {39},
number = {9},
pages = {1191--1203},
doi = {10.1016/j.cjca.2023.05.020}
}
EUVIMED